| 1. |
劉怡, 劉玉鵬, 張堯, 等. 中國1003例甲基丙二酸血癥的復雜臨床表型、基因型及防治情況分析[J]. 中華兒科雜志, 2018, 56(6): 414-420. DOI: 10.3760/cma.j.issn.0578-1310.2018.06.003.Liu Y, Liu YP, Zhang Y, et al. Heterogeneous phenotypes, genotypes, treatment and prevention of 1003 patients with methylmalonic acidemia in the mainland of China[J]. Chin J Pediatr, 2018, 56(6): 414-420. DOI: 10.3760/cma.j.issn.0578-1310.2018.06.003.
|
| 2. |
宇亞芬, 黎芳, 麻宏偉. cbIC型甲基丙二酸血癥基因型與臨床表型及療效的關系[J]. 中國當代兒科雜志, 2015, 17(8): 12-17. DOI: 10.7499/j.issn.1008-8830.2015.08.002.Yu YF, Li F, Ma HW. Relationship of genotypes with clinical phenotypes and outcomes in children with cobalamin C type combined methylmalonic aciduria and homocystinuria[J]. Chin J Contemp Pediatr, 2015, 17(8): 12-17. DOI: 10.7499/j.issn.1008-8830.2015.08.002.
|
| 3. |
Thiele J, van Raamsdonk JM. Gene discovery in methylmalonic aciduria and homocystinuria[J]. Clinical Genetics, 2006, 69(5): 402-403. DOI: 10.1111/j.1399-0004.2006.00595c.x.
|
| 4. |
Carrillo-Carrasco N, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type Ⅱ: complications, pathophysiology, and outcomes[J]. J Inherit Metab Dis, 2012, 35(1): 103-114. DOI: 10.1007/s10545-011-9365-x.
|
| 5. |
Brooks BP, Thompson AH, Sloan JL, et al. Ophthalmic manifestations and long-term visual outcomes in patients with cobalamin C deficiency[J]. Ophthalmology, 2016, 123(3): 571-582. DOI: 10.1016/j.ophtha.2015.10.041.
|
| 6. |
Weisfeld-Adams JD, Mccourt EA, Diaz GA, et al. Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance[J]. Mol Genet Metab, 2015, 114(4): 537-546. DOI: 10.1016/j.ymgme.2015.01.012.
|
| 7. |
Gizicki R, Robert MC, Gómez-López L, et al. Long-term visual outcome of methylmalonic aciduria and homocystinuria, cobalamin C type[J]. Ophthalmology, 2014, 121(1): 381-386. DOI: 10.1016/j.ophtha.2013.08.034.
|
